99
InnoCare
9969.HK·HKEXBeijing CNFounded 2015800 employees
Small CapbiotechPublicOncologyHematologyImmunology
Platform: BTK Orelabrutinib
Market Cap
$0.8B
All Drugs
2
Clinical Trials
3
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (9969.HK)
Loading 9969.HK stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Adagraratamab | 996-9552 | NDA/BLA | 1 | CFTR | HSNB | ||
| Elrasacituzumab | 996-8915 | NDA/BLA | 2 | TNFα | HSNSCLC |
SEC Filings & Financial Documents
SEC filings are not available for HKEX-listed companies.
InnoCare trades on HKEX (CN). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (2)